Wien (www.aktiencheck.de) - Merck-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
Bad Marienberg (www.aktiencheck.de)Merck trotzt Gegenwind und wächst organischDer Wissenschafts- und Technologiekonzern Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK, NASDAQ…
Trotz starker Geschäfte mit Produkten für die Arzneimittelherstellung fällt Mercks Gewinn um sechs Prozent. Die Aktionäre sollen trotzdem weiterhin eine…
MRKs Keytruda posted $31.7B in 2025 sales. Can new approvals, ongoing studies and a revamped structure keep oncology growth strong…
In the latest trading session, Merck (MRK) closed at $121.41, marking a -1.95% move from the previous day.…
Exelixis stock falls after rival Merck trial shows better results…
By John Vandermosten, CFANASDAQ:LGNDREAD THE FULL LGND RESEARCH REPORTLigand Pharmaceuticals, Inc. (NASDAQ:LGND) reported 2025 results with revenues of $268 million…
Merck to lay off around 150 employees at US site amid slump in Gardasil sales…
Merck will lay off about 150 employees across its facility in North Carolina that manufactures its human papillomavirus vaccine, Gardasil,…
Image source: The Motley Fool.DateFeb. 26, 2026Call participantsChairman and Chief Executive Officer — Phillip FrostVice Chairman and President — Elias…
Image source: The Motley Fool.DATEWednesday, Feb. 25, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Terry J. RosenPresident —…
Drugmaker Merck is separating its human-health business into two divisions to offset pressures related to the patent loss of its…
Investors gave a collective meh to news that Merck & Co Inc (NYSE:MRK, XETRA:6MK) is reportedly restructuring its human-health division, with…
Merck has an attractive yield and a long history of dividend growth.…
…
BMY edges past MRK as generic headwinds bite, but new drug launches, cost cuts and a stronger 2026 outlook tilt…
Merck stock has risen more than 7% in a month on a stronger long-term outlook, but 2026 headwinds, Keytruda patent…
Nach 15 Jahren beim deutschen Pharmakonzern Merck wechselt Belén Garijo zum französischen Konkurrenten Sanofi. Der Vertrag ihres Vorgängers wird nicht…
Image source: The Motley Fool.DateTuesday, February 10, 2026 at 5:00 p.m. ETCall participantsPresident and Chief Executive Officer — Michael MorrisseyChief…
FDA approves Merck’s Keytruda for ovarian cancer treatment…
…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 150 Euro…
…
…
…
MRK posts conservative 2026 sales and EPS outlook, given acquisition charges. Keytruda, Animal Health and new drug launches are expected…
Drug developer Eikon Therapeutics , headed by Merck veteran Roger Perlmutter, was valued at about $860.3 million after its shares…
Image source: The Motley Fool.DATETuesday, Feb. 3, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChairman, President & Chief Executive Officer — Robert…
Merck KGaA (MKKGY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off…
FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA auf "Kaufen" mit einem fairen Wert von…
The pharma industry is handling big transitions, as highlighted in Mercks and Pfizers earnings, released Tuesday…
Paypal verfehlt Erwartungen +++ US-Pharmakonzern Merck korrigiert Ausblick nach unten +++ Nintendo verfehlt Gewinnerwartungen trotz Switch-2-Absatz +++ Der Newsblog.…
FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA auf "Kaufen" mit einem fairen Wert von…
These are the stocks posting the largest moves in early trading.…
Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates as the loss of patent exclusivity…
Merck & Co Inc (NYSE:MRK, XETRA:6MK) shares fell 2% at Tuesday’s opening bell after the drugmaker issued a 2026 outlook…
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Merck KGaA mit einem Kursziel von 130 Euro…
Merck tops Q4 EPS and sales estimates as Keytruda drives growth, but shares fall in pre-market trading as 2026 guidance…
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes…
Merck (MRK) reached $110.42 at the closing of the latest trading day, reflecting a +1.92% change compared to its last…
Merck (MRK) closed at $108.34 in the latest trading session, marking a +1.35% move from the prior day.…
Der vorherige Service-Geschäft-Leiter löst zum 1. Mai Kai Beckmann ab. Der Personalwechsel räumt auch auch dessen angekündigten Weg an die…
Looking beyond Wall Streets top-and-bottom-line estimate forecasts for Merck (MRK), delve into some of its key metrics to gain a…
MRKs focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health…
Merck ends acquisition talks with Revolution Medicines - WSJ…
Gardasils sharp sales slump in China and Japan puts Merck under pressure heading into Q4 earnings, with the vaccines sales…
Merck und ChemLex unterzeichnen Absichtserklärung zur Förderung der automatisierten Chemie und technologischen Innovation^EQS-News: ChemLex / Schlagwort(e): VertragMerck und ChemLex unterzeichnen…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA nach der JPMorgan Healthcare Conference auf…
…